210 related articles for article (PubMed ID: 33369443)
1. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
2. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
3. Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand.
Suttitossatam I; Satayasai W; Sinlapamongkolkul P; Pusongchai T; Sritipsukho P; Surapolchai P
Pediatr Hematol Oncol; 2020 Oct; 37(7):561-572. PubMed ID: 32543327
[TBL] [Abstract][Full Text] [Related]
4. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study.
Söderman M; Rhedin S; Tolfvenstam T; Rotzén-Östlund M; Albert J; Broliden K; Lindblom A
PLoS One; 2016; 11(6):e0157398. PubMed ID: 27309354
[TBL] [Abstract][Full Text] [Related]
5. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
[TBL] [Abstract][Full Text] [Related]
6. Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
Shinn K; Wetzel M; DeGroote NP; Keller F; Briones M; Felker J; Castellino S; Miller TP
Pediatr Blood Cancer; 2020 Nov; 67(11):e28570. PubMed ID: 32881268
[TBL] [Abstract][Full Text] [Related]
7. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract][Full Text] [Related]
10. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
[TBL] [Abstract][Full Text] [Related]
11. Effects of respiratory viruses on febrile neutropenia attacks in children.
Aldemir-Kocabaş B; Karbuz A; Pekpak E; Karahan ZC; Dolapçı İ; İnce E; Uysal Z; Yavuz G; Çiftçi E; İnce E
Turk J Pediatr; 2017; 59(5):511-519. PubMed ID: 29745111
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Toso A; Bataszew A; Farfán MJ; de la Maza V; Vergara A; Valenzuela R; Torres JP
Clin Microbiol Infect; 2017 Mar; 23(3):173-178. PubMed ID: 27856269
[TBL] [Abstract][Full Text] [Related]
13. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
[TBL] [Abstract][Full Text] [Related]
14. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
Whittle SB; Williamson KC; Russell HV
Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
[TBL] [Abstract][Full Text] [Related]
16. Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?
Delebarre M; Garnier N; Macher E; Thebaud E; Mazingue F; Leblond P; Duhamel A; Martinot A; Dubos F
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e468-74. PubMed ID: 26479996
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia.
Meena JP; Brijwal M; Seth R; Gupta AK; Jethani J; Kapil A; Jat KR; Choudhary A; Kabra SK; Dwivedi SN; Dar L
Pediatr Hematol Oncol; 2019 Sep; 36(6):330-343. PubMed ID: 31512959
[No Abstract] [Full Text] [Related]
18. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
[TBL] [Abstract][Full Text] [Related]
19. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up.
Alexandropoulou O; Kossiva L; Haliotis F; Giannaki M; Tsolia M; Panagiotou IP; Karavanaki K
Eur J Pediatr; 2013 Jun; 172(6):811-9. PubMed ID: 23408310
[TBL] [Abstract][Full Text] [Related]
20. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
